Fulltext present in this item

Thumbnail
Fulltext: 205178.pdf
Format: PDF
Description: publisher's version
Embargo: until further notice
Title: Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report
Author(s): Radder, D.L.M.; Groenestege, A.T. Tiel; Boers, I.; Muilwijk, E.W. ; Bloem, B.R.
Publication year: 2019
Source: Journal of Parkinson's Disease, vol. 9, iss. 2, (2019), pp. 437-439
ISSN: 1877-7171
DOI: https://doi.org/10.3233/JPD-181500
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/205178   https://hdl.handle.net/2066/205178

Display more details
Subject: Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience
Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences
Organization: Neurology
Clinical Pharmacy
Journal title:
Journal of Parkinson's Disease
Volume: vol. 9
Issue: iss. 2
Page start: p. 437
Page end: p. 439
Abstract:
We present a 48-year-old woman with Parkinson's disease in whom carbidopa was added to Mucuna pruriens, resulting in marked motor improvement (documented on video and using MDS-UPDRS motor scores). This case report shows that adding a dopa-decarboxylase inhibitor (DDCI) to Mucuna pruriens could fit well in a personalized approach for patients who are reluctant to start levodopa. Meanwhile, larger trials with a longer follow-up are needed to establish the true effects and tolerability of Mucuna pruriens plus a DDCI.

This item appears in the following Collection(s)

Browse

Statistics